Awakn Life Sciences Announces the Findings from the Phase II A/B Study Are to Be Published in the American Journal of Psychiatry Psychedelics Investing
COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder Psychedelics Investing
Goodness Growth Holdings Announces Planned Divestiture of Arizona Dispensary License Cannabis Investing News
Goodness Growth Holdings to Report Third Quarter Results on November 10, 2021 Cannabis Investing News
Awakn Life Sciences to Participate at the Wonderland: Miami Conference in November 2021 Psychedelics Investing
Goodness Growth Holdings Subsidiary Vireo Health of New York Launches Whole Flower Cannabis Cannabis Investing News
InvestmentPitch Media Video Discusses LOVE Pharma's Launch of its First Two Products, BLOOM and AURALIEF - Video Available on Investmentpitch.com Pharmaceutical Investing
Levitee Clinics and Levitee Pharmacies Provide Insight on Integrated Acquisition Strategy for its Addiction and Pain Services Psychedelics Investing
Awakn Life Sciences Identifies New Chemical Series via Its Drug Discovery Program Psychedelics Investing
